ADD-ON CLEVUDINE THERAPY IN PATIENTS WITH ADEFOVIR DIPIVOXIL RESISTANT CHRONIC HEPATITIS B: IN COMPARISON WITH ADD-ON LAMIVUDINE THERAPY

被引:0
|
作者
Park, Neung Hwa [2 ]
Chung, Young-Hwa [1 ]
Kim, Jeong A. [1 ]
Kim, Sung Eun [1 ]
Lee, Yoon-Seon [1 ]
Lee, Donbi [1 ]
Lee, Soe Hwan [1 ]
Shin, Jung Woo [2 ]
Kim, Kong Mo [1 ]
Lee, Han Chu [1 ]
Lee, Yung Song [1 ]
Suh, Dong Jin [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
961
引用
收藏
页码:738A / 738A
页数:1
相关论文
共 50 条
  • [31] Felbamate as add-on therapy
    Li, LM
    Nashef, L
    Moriarty, J
    Duncan, JS
    Sander, JWAS
    [J]. EUROPEAN NEUROLOGY, 1996, 36 (03) : 146 - 148
  • [32] Comparative meta-analysis of adefovir dipivoxil monotherapy and combination therapy of adefovir dipivoxil and lamivudine for lamivudine-resistant chronic hepatitis B
    Chen, YongFa
    Ju, Ting
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2012, 16 (03) : E152 - E158
  • [33] Urinary β-2 Microglobulin Levels Sensitively Altered in an Osteomalacia Patient Receiving Add-on Adefovir Dipivoxil Therapy for Hepatitis B Virus Infection
    Takagi, Junko
    Morita, Hiroyuki
    Ito, Kiyoaki
    Ohashi, Tomohiko
    Hirase, Sho
    Ito, Tatsuo
    Morishima, Takkan
    Otake, Kazuo
    Yoneda, Masashi
    [J]. INTERNAL MEDICINE, 2016, 55 (12) : 1599 - 1603
  • [34] COMPARISON ADEFOVIR AND LAMIVUDINE COMBINATION THERAPY WITH ADEFOVIR MONOTHERAPY IN LAMIVUDINE RESISTANT CHRONIC HEPATITIS B
    Park, Woo Young
    Hwang, Jaeseok
    Jang, Byoung Kuk
    Shin, Jung Woo
    Park, Neung Hwa
    Lee, Byung Seok
    Lee, Joon Hyoek
    Bae, Si Hyun
    Tak, Won Young
    Lee, June Sung
    Lee, Chun Kyon
    Baik, Soon Koo
    Lee, Tae Hee
    Lee, Youn Jae
    [J]. HEPATOLOGY, 2009, 50 (04) : 531A - 532A
  • [35] Concerns and Safety of Add-on Versus Switch Peginterferon Therapy for Chronic Hepatitis B
    Vyas, Ashish Kumar
    Jindal, Ankur
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : 1190 - 1191
  • [36] Ranolazine as add-on therapy for patients with severe chronic angina
    Hooper, JS
    Busti, AJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (16): : 1959 - 1959
  • [37] FOUR YEARS OF ADEFOVIR ADD-ON IN 145 LAMIVUDINE RESISTANT PATIENTS WITH CHRONIC HEPATITIS B: LOW RISK OF GENOTYPIC RESISTANCE TO ADV AND PREVENTION OF VIROLOGIC BREAKTHROUGH
    Lampertico, Pietro
    Vigano, Mauro
    Facchetti, Floriana
    Lavarone, Massimo
    Colombo, Massimo
    [J]. HEPATOLOGY, 2008, 48 (04) : 712A - 712A
  • [38] ADEFOVIR DIPIVOXIL ADD-ON TREATMENT TO LAMIVUDINE RESISTANT HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS. 5-YEAR FOLLOW-UP DATA OF AN ONGOING PROSPECTIVE STUDY
    Hadziyannis, Stephanos J.
    Rapti, Irene
    Dimou, Evangelini
    [J]. HEPATOLOGY, 2008, 48 (04) : 721A - 721A
  • [39] Triple therapy with saxagliptin and dapagliflozin add-on to metformin: safety of dual add-on versus sequential add-on
    Garcia-Sanchez, R.
    Del Prato, S.
    Matthaei, S.
    Iqbal, N.
    Hansen, L.
    Johnsson, E.
    Chen, H.
    Chin, A. J.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2015, 58 : S356 - S356
  • [40] Approaches to drug resistant epilepsy: Add-on therapy
    Tomson, T
    [J]. EPILEPSIA, 2005, 46 : 414 - 414